ALNYLAM PHARMACEUTICALS, INC. (ALNY) has 204 open-market insider trades by 30 insiders since 2006. Over the last six months insiders net sold $399K. The most active filer is John Maraganore, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Sanofi | 10% Owner | — | 6 | $2.0B | 2017-05-31 |
| John Maraganore | CEO | — | 25 | $94.8M | 2021-12-22 |
| Yvonne Greenstreet | CEO | — | 24 | $73.1M | 2026-09-19 |
| Akshay Vaishnaw | Pres | — | 16 | $44.3M | 2023-08-04 |
| Barry E. Greene | Pres | — | 9 | $42.9M | 2020-09-09 |
| Pharma Ag Novartis | 10% | — | 3 | $36.7M | 2012-09-20 |
| Laurie Keating | CLOVP | — | 15 | $32.0M | 2021-08-05 |
| Phillip A. Sharp | Dir | — | 5 | $21.3M | 2025-01-23 |
| Peter Barrett | Dir | — | 5 | $13.4M | 2006-03-07 |
| Pushkal Garg | VP | — | 13 | $13.4M | 2026-03-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Bryan Supran | CLO & VP +1 | Sell | $399K | 2026-10-02 |
| David E. I. Pyott | Director | Sell | $1.1M | 2026-06-01 |
| Melissa McLaughlin | CHRO | Sell | $1.3M | 2026-04-02 |
| Pushkal Garg | VP | Sell | $1.5M | 2026-03-04 |
| Kevin Joseph Fitzgerald | CSO & VP | Sell | $418K | 2026-03-04 |
| Tolga Tanguler | CCO & VP | Sell | $746K | 2026-03-04 |
Companies that share insiders with ALNY, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jeffrey V. Poulton | CFO & VP | Sell | $797K | 2026-03-04 |
| Yvonne Greenstreet | CEO | Sell | $948K | 2026-03-04 |
| Kevin Joseph Fitzgerald | CSO & VP | Sell | $1.1M | 2026-03-02 |
| Tolga Tanguler | CCO & VP | Sell | $524K | 2026-03-02 |
| Jeffrey V. Poulton | CFO & VP | Sell | $723K | 2026-03-02 |
| Pushkal Garg | VP | Sell | $1.1M | 2026-03-02 |
| Yvonne Greenstreet | CEO | Sell | $2.2M | 2026-03-02 |
| Pushkal Garg | VP | Sell | $1.5M | 2026-02-27 |
| Kevin Joseph Fitzgerald | CSO & EVP & Head of Research | Sell | $1.3M | 2026-02-13 |